Team:DTU-Denmark/Project/POC MAGE

Overview

In order for MAGE (Multiplex Automated Genome Engineering) to work at a high efficiency, a strain with inserted recombinase and inhibited or knocked out mismatch repair gene has to be used [1]. In our project, two different recombinases were used: a recombination protein Beta from the E. coli phage Lambda, which was codon optimized for B. subtilis 168, and GP35, a recombinase from the B.subtilis phage SPP1 [2]. The mismatch repair proteins known as MutS and MutL were knocked out by transforming pSB1C3_recombinase plasmid into the B. subtilis W168. Since the MutL protein is dependent on the binding of MutS, the knockout of the mutS disables the function of the MutL protein [3].
Four Bacillus subtilis strains which expressed a recombinase were created by genetically engineering the wild type strain 168:

  • ∆amyE::beta-neoR
  • ∆amyE::GP35-neoR
  • ∆mutS::beta-neoR
  • ∆mutS::GP35-neoR

For proof of concept we decided to make a single protein substitution in the ribosomal S12 protein in B. subtilis results in resistance to the antibiotic streptomycin. The required change is a lysine to arginine substitution at position 56 of the protein. The S12 subunit is coded by the rpsL gene [4]. An oligo that could integrate this change was design using MODEST [5]. This oligos were successfully integrated into the two strains: ​∆mutS::beta-neoR and ∆mutS::GP35-neoR.

Achievements

  • Made Bacillus subtilis 168 WT MAGE compatible
  • Showed that the MODEST program can make oligoes that can be inserted in Bacillus. subtilis 168.
  • Introducing Multiplex Automated Genome Engineering (MAGE) in Bacillus  subtilis 168.

MAGE competent strains

All the strain were made by homologous recombineering. Plasmids containing cassettes that were able to do a double-crossover homologous recombineering into the genome of B. subtilis 168 (referred to as knockout (KO) plasmid). These were used to, simultaneously, delete the desired gene (amyE or mutS) and inserting the expression cassette for one of the recombinases: beta or GP35.

Figur 1. Shows the general concepts of the two plasmids pDG268neo_recombinase and pSB1C3_recombinase. Both exists in two versions, one with each of the recombinase proteins CDSs (Beta and GP35). Those also have different RBSs since they are optimized for the CDS. Upstream of neoR is a promoter and RBS and downstream of neoR is a terminator, but sequences and positions of these features are not known.

 

Four different plasmids was assembled to make the four MAGE ready strains:
pDG268neo_Beta-neoR
pDG268neo_GP35-neoR
pSB1C3_Beta-neoR
pSB1C3_GP35-neoR

 

For pDG268neo_recobinase a DNA sequence containing following features

●      Promoter: PliaG from BBa_K823002 was used.

●      RBSs were optimized for the specific CDS using the salis lab RBS calculator (https://www.denovodna.com/software/)

●      CDS for recombination protein beta or GP35

●      Terminator: we use rho-independent Part:BBa_B0014

Recobinase Sequence
Fused beta gblocks TACTGACGTAAGATTACGGGTCGACCGGGAAGTCAATGTATGAATGGATACGGGATATGAATCAATAAGTACGTGAAAGAGAAAAGCAACCCAGATATGATAGGGAACTTTTCTCTTTCTTGTTTTACATTGAATCTTTACAATCCTATTGATATAATCTAAGCTAGTGTATTTTGCGTTTAATAGTATCGACGGGAGCATCGGTAGCAGAAGGAGGTAAAAATGGCAACTAAAAAACAAGAGGAATTAAAAAACGCACTAGCACAACAAAACGGAGCCGTTCCGCAAACACCAGTCAAGCCGCAGGATAAAGTAAAGGGCTATCTCGAAAGAATGATGCCAGCTATTAAAGATGTGTTGCCTAAGCATTTAGACGCTGATCGACTTTCCCGCATCGCAATGAACGTCATTAGGACTAACCCGAAACTTCTGGAATGTGATACGGCATCACTCATGGGGGCTGTGCTGGAGTCAGCTAAATTAGGAGTGGAGCCGGGACTTTTGGGACAAGCGTATATTTTGCCGTACACGAATTACAAAAAGAAAACGGTTGAAGCTCAGTTCATTCTTGGTTATAAGGGCCTCCTTGATCTCGTGAGACGCTCTGGACACGTGAGCACAATCAGCGCTCAAACTGTTTACAAAAACGACACATTCGAATATGAATATGGGTTAGATGACAAGCTTGTTCACAGACCCGCACCATTCGGAACAGACAGAGGGGAGCCAGTTGGATACTACGCTGTAGCGAAAATGAAGGATGGCGGATATAACTTCCTTGTCATGAGTAAACAGGATGTCGAGAAACACCGGGACGCCTTTTCCAAGTCTAAAAACAGAGAGGGAGTAGTGTATGGCCCATGGGCTGACCACTTCGACGCAATGGCGAAAAAGACAGTCTTGCGCCAGCTTATCAACTATTTACCTATCAGTGTTGAGCAATTATCAGGAGTAGCGGCAGACGAACGGACAGGATCAGAACTTCATAACCAATTTGCGGATGACGACAACATTATTAACGTCGATATCAATACAGGTGAAATCATTGACCATCAAGAAAAATTAGGAGGGGAAACAAATGAATAATAATCACACTGGCTCACCTTCGGGTGGGCCTTTCTGCGTTTATATACTAGAGAGAGAATATAAAAAGCCAGATTATTAATCCGGCTTTTTTATTATTTTCGATCAGACCAGTTTTTAATTTGTGTGTT
Fused GP35 gblocks  

Sequence was ordered from IDT as two gblocks (for each recombinase) with overlapping regions, thus they can be assembled with Gibsom assembly.

 

pDG268neo was linearized in a PCR with primers, so that the native lacZ was omitted. This linearized plasmid was purified and used in a Gibsom assembly reaction with two cognate gblocks.

Figur 2. Gibsom assembly of the pDG268neo_GP35, the gblocks was fused to the “gp35 Gblocks fused” in the same reaction. The Gibsom assembly of pDG268neo_beta was similar.

 

This resulted in two different plasmids pDG268neo_beta and pDG268neo_gp35.

 

The two mutS KO plasmids was made of the following DNA fragments:

1.     About 500 bp up- and downstream from mutS was amplified, using primers with tails.

2.     Recombinase and neoR expression cassettes was amplified from the pDG268neo_recombinase

3.     Linearized pSB1C3 was used as template.

 

These fragments was assembled into two different plasmids pSB1C3_mutS::beta-neoR and pSB1C3_mutS::gp35-neoR using Gibsom assembly.

 

Figur 3. Gibsom assembly of the pSB1C3_beta. The feature called “mutL” corresponding mutS downstream. The Gibsom assembly of pSB1C3_GP35 was similar.

All plasmids were verified by restriction enzyme digestion.

We prepared naturel competent B. subtilis 168 to be transformed. The plasmids were linearized with restriction enzymes. Then transformed into naturally competent B. subtilis 168, transformants were selected on 5ɣ neo. Transformants were verified with colony PCRs.

Methods for proof of concept

Electroporation competent cells were prepared in following the protocol: Electroporation competent Bacillus subtilis 168. Electropration was carried out according to the MAGE in Bacillus subtilis 168 protocol. The colonies from the LB plates were colonies picked onto an LB and LB + 500y streptomycin (strep) plates. Plates were incubated at 37 degC for 48 hours and CFUs were counted on both the LB and the strep plates.Results

  Total number of CFUs Number of transformant Transformation frequency
ΔmutS::beta-neoR 52 7 0.13
ΔmutS::GP35-neoR 100 1 0.01

Table 1. shows the data for the MAGE proof of concept.

 

Second replication of the plates:

Figur 4. Pictures shows the first and second replication of the transformants. From left to right of ΔmutS::GP35-neoR  replicate1ΔmutS::GP35-neoR replicate2 , ΔmutS::beta-neoreplica1, and ΔmutS::beta-neoreplica2.

Discussion

The results of this proof of concept indicates that MAGE works in two of the MAGE compatible strains ΔmutS::beta-neoR and ΔmutS::GP35-neoR. More thoroughly experiments needs to be done. The result suggest that the beta protein is a more effective recombinase for the type of oligo used in this experiment.

References

  1. Carr, P. A., Wang, H. H., Sterling, B., Isaacs, F. J., Lajoie, M. J., Xu, G., … Jacobson, J. M. (2012). Enhanced multiplex genome engineering through co-operative oligonucleotide co-selection. Nucleic Acids Research, 40(17). doi:10.1093/nar/gks455
  2. Sun, Z., Deng, A., Hu, T., Wu, J., Sun, Q., Bai, H., … Wen, T. (2015). A high-efficiency recombineering system with PCR-based ssDNA in Bacillus subtilis mediated by the native phage recombinase GP35. Applied Microbiology and Biotechnology, 99(12), 5151–5162. doi:10.1007/s00253-015-6485-5
  3. Ginetti, F., Perego, M., Albertini, A. M., & Galizzi, A. (1996). Bacillus subtilis mutS mutL operon: Identification, nucleotide sequence and mutagenesis. Microbiology, 142(8), 2021–2029. doi:10.1099/13500872-142-8-2021
  4. Barnard, A. M. L., Simpson, N. J. L., Lilley, K. S., & Salmond, G. P. C. (2010). Mutations in rpsL that confer streptomycin resistance show pleiotropic effects on virulence and the production of a carbapenem antibiotic in Erwinia carotovora. Microbiology, 156(4), 1030–1039. <a href="http://dx.doi.org/10.1099/mic.0.034595-0" target="_blank">doi:10.1099/mic.0.034595-0</a>
  5. Bonde, M. T., Klausen, M. S., Anderson, M. V., Wallin, A. I. N., Wang, H. H., & Sommer, M. O. A. (2014). MODEST: a web-based design tool for oligonucleotide-mediated genome engineering and recombineering. Nucleic Acids Research, 42(W1), W408–W415. doi:10.1093/nar/gku428
Technical University of Denmark
Department of Systems Biology
Søltofts Plads 221
2800 Kgs. Lyngby
Denmark
P: +45 45 25 25 25
M: dtu-igem-2015@googlegroups.com